Dear Friends and Colleagues, My heartiest greetings to all of you! As we are getting closer to the APAAACI 2022 Congress PSAAI@50, on behalf of APAAACI and PSAAI, we welcome all our colleagues from Asia Pacific and beyond to APAAACI 2022 Congress PSAAI@50 that will take place in Manila from 5-8 December 2022.
With an outstanding scientific program delivered by world renowned international and regional faculty, the congress brings to you the best of science and clinical updates in allergy, asthma & clinical immunology. For more details click here
In a culturally unique setting of the city of Manila, the congress also offers plenty of networking opportunities with established and upcoming young leaders in allergy, asthma & clinical immunology.
We are delighted to announce that the Congress is extending preferential rates for group registrations for international attendees
For any further information and assistance, please contact us on email@example.com We look forward to seeing you in Manila!
APAAACI proudly announces the registration of its Association under the Dubai Association Centre (DAC)
Dubai is a cosmopolitan city and an international business hub that will be an added value to our association’s development and success, therefore our registration under the auspices of the Dubai Association Centre will contribute to APAAACI’s growth and development. This will further broaden our horizons and reinforce APAAACI’s reach to the region and beyond. Thanking all of you for your continued support and encouragements. We will continue to take APAAACI to new heights and serve our APAAACI family in the region and beyond while collaborating and leveraging with global bodies.
APAAACI MASTERCLASS on Severe Allergies: Current concepts on the mechanisms and management strategies
We successfully organized another APAAACI MasterClass, on 11th October 2022, with the theme: Severe Allergies: Current concepts on the mechanisms and management strategies. This forum was be moderated by Prof. Pongsakorn Tantilipikorn (Thailand), comprised of lectures led by our leading international experts, Prof. Giorgio Walter Canonica (Italy) & Prof. Glenis Scadding (United Kingdom). We received great appreciation on the outstanding talks and contents. Webinar had over 1060 registrations from 63 countries, from the region and beyond.
APAAACI MASTERCLASS - Addressing Severe Allergies: Webinar Series II
We are excited to announce our upcoming APAAACI MasterClass, on 8th November 2022, with the theme: Addressing Severe Allergies. Live simultaneous translation for Chinese delegates will be provided for this masterclass. The MasterClass will be led by our international leading expert, Prof. Jean Bousquet (France) and with lectures from regional leading experts, Prof. Pete Smith (Australia), Prof. Luo Zhang (China) & Prof. Pongsakorn Tantilipikorn (Thailand). This forum is scheduled on 8th November 2022, 18:00-19:30hrs (CST/SGT/HKT/MYT). For the program details and registration, refer below.
APAAACI Sister Society Symposium at World Allergy Congress (WAC) 2022
The World Allergy Organization (WAO) in collaboration with the Turkish National Society of Allergy and Clinical Immunology (TNSACI) hosted the World Allergy Congress 2022 in Istanbul, Turkey from 13-15 October 2022. APAAACI congratulate WAO and TNSACI for a very successful congress and an outstanding scientific program led by Prof. Mubeccel Akdis and her team. We wish them continued success in all their future endeavours! APAAACI proudly contributed to the World Allergy Congress 2022 by delivering a Sister Society Symposium on the topic ''Allergies, Asthma and Viral Infections: Current Perspectives & Future Directions'' as below. The session was well attended with a vibrant discussion.
Our committee leaders and JAAFCA members are continuing to be actively involved in developing consensus documents/state of the art review papers and implementation of other initiatives. Currently we have several surveys in progress namely, • SURVEY ON HEREDITARY ANGIOEDEMA (HAE) • SURVEY ON PENICILLIN ALLERGY • SURVEY ON IGE-MEDIATED FOOD ALLERGY DIAGNOSIS AND MANAGEMENT Stay tuned for more updates!
JAAFCA: Flagship Program of APAAACI
APAAACI expresses its deepest gratitude and congratulate all the JAAFCA members specially the steering committee, for their continuous contribution to the scientific initiatives for APAAACI as well as for the APAAACI Congress. JAAFCA members forms the soul of the organization.
Highlights of the Allergy World
Update on mosquito bite reaction: Itch and hypersensitivity, pathophysiology, prevention, and treatment Vander Does A, Labib A, Yosipovitch G. Front Immunol. 2022 Sep 21;13:1024559. doi: 10.3389/fimmu.2022.1024559. PMID: 36211437; PMCID: PMC9532860. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update - XIII - Oral immunotherapy for CMA - Systematic review Bognanni A, Chu DK, Firmino RT, Arasi S, Waffenschmidt S, Agarwal A, Dziechciarz P, Horvath A, Jebai R, Mihara H, Roldan Y, Said M, Shamir R, Bozzola M, Bahna S, Fiocchi A, Waserman S, Schünemann HJ, Brożek JL; WAO DRACMA Guideline Group. World Allergy Organ J. 2022 Sep 8;15(9):100682. doi: 10.1016/j.waojou.2022.100682. PMID: 36185550; PMCID: PMC9474924. A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies - an EAACI Position paper Vazquez-Ortiz M, Gore C, Alviani C, Angier E, Blumchen K, Comberiati P, Duca B, DunnGalvin A, Garriga-Baraut T, Gowland MH, Egmose B, Knibb R, Khaleva E, Mortz CG, Pfaar O, Pite H, Podesta M, Santos AF, Sanchez-Garcia S, Timmermans F, Roberts G. Allergy. 2022 Sep 29. doi: 10.1111/all.15533. Epub ahead of print. PMID: 36176045. Treatment of hereditary angioedema-single or multiple pathways to the rescue Valerieva A, Longhurst HJ. Front Allergy. 2022 Sep 12;3:952233. doi: 10.3389/falgy.2022.952233. PMID: 36172291; PMCID: PMC9510393. Allergen Immunotherapy for Atopic Dermatitis: A Systematic Review and Meta-Analysis of Benefits and Harms Yepes-Nuñez JJ, Guyatt GH, Gómez-Escobar LG, Pérez-Herrera LC, Chu A, Ceccaci R, Acosta-Madiedo AS, Wen A, Moreno-López S, MacDonald M, Barrios M, Chu X, Islam N, Gao Y, Wong MM, Couban R, Garcia E, Chapman E, Oykhman P, Chen L, Winders T, Asiniwasis RN, Boguniewicz M, De Benedetto A, Ellison K, Frazier WT, Greenhawt M, Huynh J, BscPhm EK, LeBovidge J, Lind ML, Lio P, Martin SA, O'Brien M, Ong PY, Silverberg JI, Spergel J, Wang J, Wheeler KE, Schneider L, Chu DK. J Allergy Clin Immunol. 2022 Sep 30:S0091-6749(22)01322-7. doi: 10.1016/j.jaci.2022.09.020. Epub ahead of print. PMID: 36191689. Electronic Cigarettes: A Pro-Con Review of the Current Literature Coral X. Giovacchini, Laura E. Crotty Alexander, Loretta G. Que. J Allergy Clin Immunol Pract. 2022 The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis Jean Bousquet, Mondher Toumi, Bernardo Sousa-Pinto, Josep M. Anto, Anna Bedbrook, Wienczyslawa Czarlewski et al. J Allergy Clin Immunol Pract 2022 Validation of the Urticaria Control Test (UCT) in Children With Chronic Urticaria Connor Prosty, Sofianne Gabrielli, Pasquale Mule, Nuzha Noorah, Sharon Baum, Shoshana Greenberger et al. J Allergy Clin Immunol Pract 2022 Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics Daniel Munblit, Matthew Greenhawt, Helen A. Brough, Anna Pushkareva, Diana Karimova, Anastasia Demidova, John O. Warner et al. Pediatr Allergy Immunol. 2022;33:e13851 Control of Allergic Rhinitis and Asthma Test: A systematic review of measurement properties and COSMIN analysis Rafael José Vieira, Bernardo Sousa‐Pinto, António Cardoso‐Fernandes, Cristina Jácome, Diana Portela, Rita Amaral et al. Clin Transl Allergy. 2022;e12194.
Website Editor: Prof. Bernard Thong Website Co-Editor: Prof. Amir HA Latiff
Professor Ruby Pawankar